Search

everythinglearnresearchcommunity

for

Search:↓

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

TCDD reduces EGF receptors in the liver, affecting growth and development.

CD4+ skin cells may be precursors to basal cell carcinoma.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Double stranded RNA helps skin wounds heal by coordinating specific proteins and signaling pathways.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Baicalin may help treat severe drug-induced skin reactions.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

CD90 is abundantly present on stem-like cells in dog hair follicles.

MARCKSL1 is important for wound healing and could be a target to reduce scarring.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.